Cargando…

Preparation and Quality Control of the [(153)Sm]-Samarium Maltolate Complex as a Lanthanide Mobilization Product in Rats

Development of lanthanide detoxification agents and protocols is of great importance in management of overdoses. Due to safety of maltol as a detoxifying agent in metal overloads, it can be used as a lanthanide detoxifying agent. In order to demonstrate the biodistribution of final complex, [(153)Sm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naseri, Zohreh, Hakimi, Amir, Jalilian, Amir R., Nemati Kharat, Ali, Bahrami-Samani, Ali, Ghannadi-Maragheh, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Österreichische Apotheker-Verlagsgesellschaft 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134855/ https://www.ncbi.nlm.nih.gov/pubmed/21773065 http://dx.doi.org/10.3797/scipharm.1011-08

Ejemplares similares

Treatment efficacy of (153)Sm-EDTMP for painful bone metastasis
por: Ayati, Narjess, et al.
Publicado: (2013)

Production, Quality Control and Biological Evaluation of (166)Ho-PDTMP as a Possible Bone Palliation Agent
por: Zolghadri, Samaneh, et al.
Publicado: (2013)

Development of (166)Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent
por: Zolghadri, Samaneh, et al.
Publicado: (2014)

Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [$^{153}$Sm]Sm-DOTA-TATE
por: Vermeulen, Koen, et al.
Publicado: (2022)

Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [(153)Sm]Sm-DOTA-TATE
por: Vermeulen, Koen, et al.
Publicado: (2022)

Production, Quality Control and Pharmacokinetic Studies of (166)Ho-EDTMP for Therapeutic Applications
por: Bahrami-Samani, Ali, et al.
Publicado: (2010)

Development of (177)Lu-phytate Complex for Radiosynovectomy
por: Yousefnia, Hassan, et al.
Publicado: (2013)

Production, Quality Control and Pharmacokinetic Studies of (177)Lu-EDTMP for Human Bone Pain Palliation Therapy Trials
por: Bahrami-Samani, Ali, et al.
Publicado: (2012)

Development of Ga-67 Maltolate Complex as an Imaging Agent
por: Fazaeli, Yousef, et al.
Publicado: (2012)

[(153)Sm]Samarium-labeled FAPI-46 radioligand therapy in a patient with lung metastases of a sarcoma
por: Kratochwil, Clemens, et al.
Publicado: (2021)

Beyond Palliation: Therapeutic Applications of (153)Samarium-EDTMP
por: Wilky, Breelyn A., et al.
Publicado: (2013)

Production, biodistribution assessment and dosimetric evaluation of (177)Lu-TTHMP as an agent for bone pain palliation
por: Zolghadri, Samaneh, et al.
Publicado: (2015)

Samarium Monosulfide (SmS): Reviewing Properties and Applications
por: Sousanis, Andreas, et al.
Publicado: (2017)

Production and quality control (177)Lu (NCA)—DOTMP as a potential agent for bone pain palliation
por: Salek, Nafise, et al.
Publicado: (2016)

Separation of samarium and europium by solvent extraction with an undiluted quaternary ammonium ionic liquid: towards high-purity medical samarium-153
por: Van de Voorde, Michiel, et al.
Publicado: (2018)

Synovectomy using Samarium-153 Hydroxyapatite in the Elbows and Ankles of Patients with Hemophilic Arthropathy
por: Manzzini Calegaro, José Ulisses, et al.
Publicado: (2018)

Lithium samarium polyphosphate, LiSm(PO(3))(4)
por: Zhao, Dan, et al.
Publicado: (2010)

Preparation and Use of Samarium Diiodide (SmI(2)) in Organic Synthesis: The Mechanistic Role of HMPA and Ni(II) Salts in the Samarium Barbier Reaction
por: Sadasivam, Dhandapani V., et al.
Publicado: (2013)

The use of 185 MBq and 740 MBq of 153-samarium hydroxyapatite for knee synovectomy in haemophilia
por: Calegaro, J U M, et al.
Publicado: (2014)

Effects of low-dose capecitabine on Samarium-153-EDTMP therapy for painful bone metastases
por: Barai, Sukanta, et al.
Publicado: (2015)

Comparison of Image Quality of Different Radionuclides Technetium-99m, Samarium-153, and Iodine-123
por: Bouzekraoui, Youssef, et al.
Publicado: (2019)

Development of (153)Sm-DTPA-SPION as a theranostic dual contrast agents in SPECT/MRI
por: Gholami, Amir, et al.
Publicado: (2016)

Systemic Radiopharmaceutical Agents (Sm-153) may be Dangerous in Hepatacellular Carcinoma
por: Keskin, Onur, et al.
Publicado: (2015)

Optimal Timing of Bisphosphonate Administration in Combination with Samarium-153 Oxabifore in the Treatment of Painful Metastatic Bone Disease
por: Rasulova, Nigora, et al.
Publicado: (2013)

Neutron Activated Samarium-153 Microparticles for Transarterial Radioembolization of Liver Tumour with Post-Procedure Imaging Capabilities
por: Hashikin, Nurul Ab. Aziz, et al.
Publicado: (2015)

Preparation and Quality Control of (68)Ga-Citrate for PET Applications
por: Aghanejad, Ayuob, et al.
Publicado: (2015)

Preparation and In Vitro Evaluation of Neutron-Activated, Theranostic Samarium-153-Labeled Microspheres for Transarterial Radioembolization of Hepatocellular Carcinoma and Liver Metastasis
por: Wong, Yin How, et al.
Publicado: (2019)

The influence of Sm-153 therapy on bone marrow function
por: Małkowski, Bogdan, et al.
Publicado: (2016)

Sodium samarium tetrakis(polyphosphate), NaSm(PO(3))(4)
por: Zhao, Dan, et al.
Publicado: (2010)

The Level of Europium-154 Contaminating Samarium-153-EDTMP Activates the Radiation Alarm System at the US Homeland Security Checkpoints
por: Najeeb Al Hallak, Mohammed, et al.
Publicado: (2009)

Neutron-activated biodegradable samarium-153 acetylacetonate-poly-L-lactic acid microspheres for intraarterial radioembolization of hepatic tumors
por: Wong, Yin-How, et al.
Publicado: (2020)

Dosimetric implications of the potential radionuclidic impurities in (153)Sm-DOTMP
por: Wendt, Richard E., et al.
Publicado: (2022)

Metastatic Bone Pain Palliation using (177)Lu-Ethylenediaminetetramethylene Phosphonic Acid
por: Alavi, Mehrosadat, et al.
Publicado: (2015)

Heteroleptic Samarium(III) Chalcogenide Complexes: Opportunities for Giant Exchange Coupling in Bridging σ- and π-Radical Lanthanide Dichalcogenides
por: Goodwin, Conrad A. P., et al.
Publicado: (2020)

Samarium-153-EDTMP (Quadramet(®)) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trial
por: Heery, Christopher R., et al.
Publicado: (2016)

Preparation, Biological Evaluation and Dosimetry Studies of 175Yb-Bis-Phosphonates for Palliative Treatment of Bone Pain
por: Fakhari, Ashraf, et al.
Publicado: (2015)

Samarium-153-ethylene diamine tetramethylene phosphonate, a beta-emitting bone-targeted radiopharmaceutical, useful for patients with osteoblastic bone metastases
por: Longo, John, et al.
Publicado: (2013)

Isolation of maltol derivatives from Stellera chamaejasme and the anti-atopic properties of maltol on skin lesions in DNCB-stimulated mice
por: Jo, Beom-Geun, et al.
Publicado: (2019)

Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy
por: Van de Voorde, Michiel, et al.
Publicado: (2021)

Comparison of Tc-99m MDP and Sm-153 EDTMP bone scan
por: Ramachandran, Krishnakumar, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tesjvm85u9u56m72q4u80k6t4q